SEC Form D private-offering filing
Aptamino, Inc.
A new SEC Form D private-offering notice from Cambridge, MA, a $8,000,002 filer-stated offering target in Biotech. The source filing is one click away.
Aptamino, Inc. Verified via SEC Form D
Biotech startup using protein design to enable oral delivery of antibodies, founded by MIT and Harvard-trained scientists Isaac Lutz and Julie Zhang
Filed 2026-04-06Filed to raise $8,000,002First money in 2026-03-17Raised so far $8,000,002HQ (as filed) Cambridge, MASector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.